AUA-IBCG Bladder Cancer Forum

The AUA - IBCG (International Bladder Cancer Group) Bladder Cancer Forum returns for 2024. This forum brings together renowned experts in urology, medical oncology, radiation oncology, and translational sciences to address common dilemmas and challenges in the management of bladder cancer through practical, case-based debates.

For further details about the International Bladder Cancer Group, please visit https://www.ibcg.info/

Learning Objectives:
1. Describe the complexities related to the diagnosis and management of bladder cancer.
2. Apply existing treatment options to appropriate patients across the spectrum of disease, from non-muscle invasive to advanced, metastatic bladder cancer.
3. Compare the role of urinary biomarkers in non-muscle and muscle-invasive bladder cancer.
4. Identify the optimal cystoscopic techniques (eg blue light, en bloc, repeat TURBT, etc) in patients with high grade NMIBC.
5. Select appropriate patients for de-intensification of interventions.
6. Identify the importance of variant histology in bladder cancer management.
7. Compare management strategies in BCG-unresponsive bladder cancer.
8. Cite evidence-based approaches to surgical treatment of bladder cancer.
9. Discuss evidence supporting current bladder preservation paradigms in non-muscle invasive and muscle-invasive bladder cancer.
10. Critically evaluate evidence supporting first line therapies for advanced and metastatic bladder cancer.